The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions.

To favor bone reconstitution with biomaterials endothelial cells should maintain proper functions to drive angiogenesis. To this aim nanocrystals of hydroxyapatite (HA) have been synthesized and characterized on endothelial cells. Microvascular endothelial cells have been exposed to stoichiometric HA nanocrystals. Cell morphology and organization of cytoskeletal proteins have been monitored by SEM analysis and immunofluorescence. Biochemical markers of physiological and pathological responses of endothelial cells, endothelial constitutive nitric oxide synthase, and cycloxygenase-2 (ecNOS and COX-2, respectively) have been measured by immunofluorescence. Crystallized HA sustained endothelial survival without any cytotoxic effect. At the observation with SEM, endothelial cell morphology was maintained in the presence of HA. The localization and organization of beta-actin documented the formation of stress fibers, indicating an activation of endothelial cells induced by HA nanocrystals. Immunohistochemistry for biochemical key signaling pathways in endothelium demonstrated that nanocrystals of HA maintained the expression of ecNOS and did not increase COX-2 expression. In conclusion, the present findings indicate that HA nanocrystals exhibit high biocompatibility for microvascular endothelium. In the presence of HA nanocrystals endothelial cells maintain biochemical markers of healthy endothelium. They do not acquire a proinflammatory or thrombogenic phenotype, but express markers of functioning endothelium that might contribute to angiogenesis.

[1]  R. Franke,et al.  Plasma transglutaminase factor XIII induces microvessel ingrowth into biodegradable hydroxyapatite implants in rats. , 2005, Biomaterials.

[2]  R. Bowler,et al.  Colocalization of eNOS and the Catalytic Subunit of PKA in Endothelial Cell Junctions: A Clue for Regulated NO Production , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  Christopher P. Johnson,et al.  Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling , 2004, Cell Communication and Signaling.

[4]  W. Sessa eNOS at a glance , 2004, Journal of Cell Science.

[5]  R. Kloner,et al.  Relationship Between Cyclooxygenase-2 Inhibition and Thrombogenesis , 2004, Journal of cardiovascular pharmacology and therapeutics.

[6]  M. Gazzano,et al.  Microstructural investigation of hydroxyapatite–polyelectrolyte composites , 2004 .

[7]  S. Donnini,et al.  Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  S. Donnini,et al.  Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers , 2003, British Journal of Cancer.

[9]  Shigeyuki Ebisu,et al.  Effects of α-TCP and TetCP on MC3T3-E1 proliferation, differentiation and mineralization , 2003 .

[10]  G. Sacchi,et al.  Focal adhesion molecules expression and fibrillin deposition by lymphatic and blood vessel endothelial cells in culture. , 2002, Microvascular research.

[11]  C. Rey,et al.  Adsorption of vascular endothelial growth factor to two different apatitic materials and its release , 2001, Journal of materials science. Materials in medicine.

[12]  S. Kwon,et al.  The effects of calcium phosphate cement particles on osteoblast functions. , 2000, Biomaterials.

[13]  E. Paccagnini,et al.  HIV‐1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P , 1998, AIDS.

[14]  J. Lane,et al.  Current understanding of osteoconduction in bone regeneration. , 1998, Clinical orthopaedics and related research.

[15]  Masahiro Yoshimura,et al.  Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants , 1998 .

[16]  R Bicknell,et al.  Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. , 1997, The Journal of clinical investigation.

[17]  I. Rehman,et al.  Preparation and characterization of fluoride-substituted apatites , 1997, Journal of materials science. Materials in medicine.

[18]  C. Blitterswijk,et al.  Surface modification of hydroxyapatite to introduce interfacial bonding with polyactiveTM 70/30 in a biodegradable composite , 1996 .

[19]  L. Hench Bioceramics and the origin of life. , 1989, Journal of biomedical materials research.

[20]  L. Alexander,et al.  X-ray diffraction methods in polymer science , 1969 .

[21]  D. Freedman Senescence and its bypass in the vascular endothelium. , 2005, Frontiers in bioscience : a journal and virtual library.

[22]  Y. Liu,et al.  Evaluation of biocompatibility of various ceramic powders with human fibroblasts in vitro. , 1993, Clinical materials.

[23]  D. Williams,et al.  Mechanical properties of biomaterials , 1980 .